Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jun 9:11:1087002.
doi: 10.3389/fped.2023.1087002. eCollection 2023.

Immune dysregulation in Kabuki syndrome: a case report of Evans syndrome and hypogammaglobulinemia

Affiliations
Case Reports

Immune dysregulation in Kabuki syndrome: a case report of Evans syndrome and hypogammaglobulinemia

Lucia Leonardi et al. Front Pediatr. .

Abstract

Kabuki syndrome (KS) is a rare multisystemic disease due to mutations in the KMT2D or KDM6A genes, which act as epigenetic modulators of different processes, including immune response. The syndrome is characterized by anomalies in multiple organ systems, and it is associated with autoimmune and inflammatory disorders, and an underlying immunological phenotype characterized by immunodeficiency and immune dysregulation. Up to 17% of KS patients present with immune thrombocytopenia characterized by a severe, chronic or relapsing course, and often associated to other hematological autoimmune diseases including autoimmune hemolytic anemia, eventually resulting in Evans syndrome (ES). A 23-year-old woman, clinically diagnosed with KS and presenting from the age of 3 years with ES was referred to the Rare Diseases Centre of our Pediatric Department for corticosteroid-induced hyperglycemia. Several ES relapses and recurrent respiratory infections in the previous years were reported. Severe hypogammaglobulinemia, splenomegaly and signs of chronic lung inflammation were diagnosed only at the time of our observation. Supportive treatment with amoxicillin-clavulanate prophylaxis and recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin replacement were immediately started. In KS patients, the failure of B-cell development and the lack of autoreactive immune cells suppression can lead to immunodeficiency and autoimmunity that may be undiagnosed for a long time. Our patient's case is paradigmatic since she presented with preventable morbidity and severe lung disease years after disease onset. This case emphasizes the importance of suspecting immune dysregulation in KS. Pathogenesis and immunological complications of KS are discussed. Moreover, the need to perform immunologic evaluations is highlighted both at the time of KS diagnosis and during disease follow-up, in order to allow proper treatment while intercepting avoidable morbidity in these patients.

Keywords: Evans syndrome; Kabuki syndrome; autoimmunity; hypogammaglobulinemia; immune dysregulation; immunodeficiency.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Patient's facial features (arched and broad eyebrows, long palpebral fissures, eversion of the lower eyelid, depressed nasal tip and short columella) and persistence of fetal fingertip pads, typical of Kabuki syndrome.
Figure 2
Figure 2
Chest HRCT. (A) Images show interstitial lung disease and chronic inflammation. Note the numerous findings, including ground-glass opacity (blue circle), bronchiectasis (white arrow), nodules with blurred edges (green arrows), and regions of air trapping (red circles). (B) Radiological disease improvement with persistence of air-trapping.
Figure 3
Figure 3
Timeline of principal clinical events and therapeutic strategies.

References

    1. Niikawa N, Kuroki Y, Kajii T, Matsuura N, Ishikiriyama S, Tonoki H, et al. Kabuki make-up (Niikawa–Kuroki) syndrome: a study of 62 patients. Am J Med Genet. (1988) 31:565–89. 10.1002/ajmg.1320310312 - DOI - PubMed
    1. Cheon C-K, Ko JM. Kabuki syndrome: clinical and molecular characteristics. Korean J Pediatr. (2015) 58:317. 10.3345/kjp.2015.58.9.317 - DOI - PMC - PubMed
    1. Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, Gildersleeve HI, et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet. (2010) 42:790–3. 10.1038/ng.646 - DOI - PMC - PubMed
    1. Bögershausen N, Wollnik B. Unmasking Kabuki syndrome: unmasking Kabuki syndrome. Clin Genet. (2013) 83:201–11. 10.1111/cge.12051 - DOI - PubMed
    1. Banka S, Veeramachaneni R, Reardon W, Howard E, Bunstone S, Ragge N, et al. How genetically heterogeneous is Kabuki syndrome? MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum. Eur J Hum Genet. (2012) 20:381–8. 10.1038/ejhg.2011.220 - DOI - PMC - PubMed

Publication types